Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Expected to Release Earnings on Monday

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) is anticipated to announce its resultson Monday, July 27th. Analysts expect the company to announce earnings of $0.18 per share and revenue of $970.6930 million for the quarter.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last announced its quarterly earnings data on Tuesday, May 12th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.03. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 13.56% and a net margin of 41.08%.The firm had revenue of $881.71 million during the quarter, compared to analysts’ expectations of $895.52 million. On average, analysts expect Shionogi & Co., Ltd. Unsponsored ADR to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Stock Performance

SGIOY opened at $8.82 on Monday. Shionogi & Co., Ltd. Unsponsored ADR has a twelve month low of $7.65 and a twelve month high of $12.00. The company has a 50-day simple moving average of $8.94 and a 200 day simple moving average of $9.89. The company has a quick ratio of 1.46, a current ratio of 1.58 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $15.01 billion, a price-to-earnings ratio of 11.03, a P/E/G ratio of 3.42 and a beta of 0.09.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Zacks Research upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research note on Monday, May 25th. Jefferies Financial Group raised shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 14th. Finally, The Goldman Sachs Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research report on Monday, June 15th. Two research analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Shionogi & Co., Ltd. Unsponsored ADR currently has a consensus rating of “Buy”.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.